Evidence map›Paper›PMID 34008347›Full record

ReviewWiley interdisciplinary reviews. Nanomedicine and nanobiotechnology2021

Functionalizing DNA nanostructures for therapeutic applications.

Skylar J W Henry, Nicholas Stephanopoulos

Open access · greenAbstract readReview
In one paragraph

Review in Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Advances in Aptamer Drug Delivery Systems for Treatment of Glioblastoma.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  2. Article
  3. DNA nanocarriers for nucleic acid drug delivery.Expert opinion on drug delivery · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Nano-Bio Interactions between DNA Nanocages and Human Serum Albumin.Journal of chemical theory and computation · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Nucleic acid nanostructures forApplied physics reviews · 2023
    Review
  13. Review
  14. Review
  15. Radiolabeling and Preliminary Evaluation ofInternational journal of nanomedicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Skylar J W HenrySchool of Molecular Sciences, Biodesign Center for Molecular Design and Biomimetics, Arizona State University, Tempe, Arizona, USA.
Nicholas StephanopoulosSchool of Molecular Sciences, Biodesign Center for Molecular Design and Biomimetics, Arizona State University, Tempe, Arizona, USA.ORCID 0000-0001-7859-410X
Arizona State University · US

Funding

Chemical synthesis of G protein-coupled receptors using sequential DNA-templated reactionsDP2GM132931 · NIGMS · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI STEPHANOPOULOS, NICHOLAS · 2018 to 2018
$2.2M
NIGMS NIH HHS DP2 GM132931
6 · The paper itself

Abstract

Recent advances in nanotechnology have enabled rapid progress in many areas of biomedical research, including drug delivery, targeted therapies, imaging, and sensing. The emerging field of DNA nanotechnology, in which oligonucleotides are designed to self-assemble into programmable 2D and 3D nanostructures, offers great promise for further advancements in biomedicine. DNA nanostructures present highly addressable and functionally diverse platforms for biological applications due to their ease of construction, controllable architecture and size/shape, and multiple avenues for chemical modification. Both supramolecular and covalent modification with small molecules and polymers have been shown to expand or enhance the functions of DNA nanostructures in biological contexts. These alterations include the addition of small molecule, protein, or nucleic acid moieties that enable structural stability under physiological conditions, more efficient cellular uptake and targeting, delivery of various molecular cargos, stimulus-responsive behaviors, or modulation of a host immune response. Herein, various types of DNA nanostructure modifications and their functional consequences are examined, followed by a brief discussion of the future opportunities for functionalized DNA nanostructures as well as the barriers that must be overcome before their translational use. This article is categorized under: Nanotechnology Approaches to Biology > Nanoscale Systems in Biology Therapeutic Approaches and Drug Discovery > Emerging Technologies Biology-Inspired Nanomaterials > Nucleic Acid-Based Structures.

Indexed as

NanostructuresDNADrug Delivery SystemsNanotechnologyOligonucleotidesDNAOligonucleotidesbiomaterialsDNA nanotechnologydrug delivery

Identifiers

PMID34008347
PMCPMC8526372
OpenAlexW3160382322

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.